FREDUN PHARMACEUTICALS
Back to Income Statement
|
FREDUN PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr | ₹97 Cr |
What is the latest Revenue of FREDUN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹275 Cr |
Mar2023 | ₹224 Cr |
Mar2022 | ₹134 Cr |
Mar2021 | ₹11,277,136 Cr |
Mar2020 | ₹97 Cr |
How is Revenue of FREDUN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹275 Cr | 22.37 | |
Mar2023 | ₹224 Cr | 67.64 | |
Mar2022 | ₹134 Cr | -100.00 | |
Mar2021 | ₹11,277,136 Cr | 11,623,895.95 | |
Mar2020 | ₹97 Cr | - |
Compare Revenue of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹315.3 Cr | 0.9% | -0.6% | -16.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 0.9% |
-0.6% |
-16.6% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses